Brighton Jones’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-858
Closed -$210K – 1401
2026
Q2
$210K Buy
+858
New +$186K ﹤0.01% 1233

Other funds holding AXSM

Brighton Jones's AXSM Position: Q3 2026 in Review

Brighton Jones sold out of Axsome Therapeutics (AXSM) in Q3 2026, closing a stake of 858 shares — an estimated $210K sold.

Brighton Jones first reported a position in AXSM in Q2 2026 and held it in 1 quarter. The position peaked at $210K in Q2 2026. 385 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.

  • Brighton Jones reported no remaining Axsome Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Brighton Jones sold 858 Axsome Therapeutics shares in Q3 2026, an estimated $210K.
  • Brighton Jones first reported a position in Axsome Therapeutics in Q2 2026 and held it in 1 quarter.
  • Brighton Jones's Axsome Therapeutics position peaked at $210K in Q2 2026.
  • 385 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.